Freedland SJ - Search Results

1

Natural killer cell activity and prostate cancer risk in veteran men undergoing prostate biopsy.

Vidal AC, Howard LE, Wiggins E, De Hoedt AM, Shiao SL, Knott S, Taioli E, Fowke JH, Freedland SJ. Vidal AC, et al. Among authors: freedland sj. Cancer Epidemiol. 2019 Oct;62:101578. doi: 10.1016/j.canep.2019.101578. Epub 2019 Aug 1. Cancer Epidemiol. 2019. PMID: 31377571 Free PMC article.

2

Clinical characteristics in black and white men with prostate cancer in an equal access medical center.

Freedland SJ, Sutter ME, Naitoh J, Dorey F, Csathy GS, Aronson WJ. Freedland SJ, et al. Urology. 2000 Mar;55(3):387-90. doi: 10.1016/s0090-4295(99)00461-6. Urology. 2000. PMID: 10699616

3

Race is not an independent predictor of biochemical recurrence after radical prostatectomy in an equal access medical center.

Freedland SJ, Jalkut M, Dorey F, Sutter ME, Aronson WJ. Freedland SJ, et al. Urology. 2000 Jul;56(1):87-91. doi: 10.1016/s0090-4295(00)00587-2. Urology. 2000. PMID: 10869631

4

Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score.

Freedland SJ, Csathy GS, Dorey F, Aronson WJ. Freedland SJ, et al. J Urol. 2002 Feb;167(2 Pt 1):516-20. doi: 10.1016/S0022-5347(01)69076-1. J Urol. 2002. PMID: 11792909

5

Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.

Freedland SJ, Wieder JA, Jack GS, Dorey F, deKernion JB, Aronson WJ. Freedland SJ, et al. J Urol. 2002 Jul;168(1):110-5. J Urol. 2002. PMID: 12050502

6

Clinical utility of percent prostate needle biopsy tissue with cancer cutpoints to risk stratify patients before radical prostatectomy.

Freedland SJ, Csathy GS, Dorey F, Aronson WJ. Freedland SJ, et al. Urology. 2002 Jul;60(1):84-8. doi: 10.1016/s0090-4295(02)01660-6. Urology. 2002. PMID: 12100929

7

Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base.

Freedland SJ, Kane CJ, Presti JC Jr, Terris MK, Amling CL, Dorey F, Aronson WJ. Freedland SJ, et al. J Urol. 2003 Mar;169(3):969-73. doi: 10.1097/01.ju.0000051400.85694.bb. J Urol. 2003. PMID: 12576824

8

Defining the ideal cutpoint for determining PSA recurrence after radical prostatectomy. Prostate-specific antigen.

Freedland SJ, Sutter ME, Dorey F, Aronson WJ. Freedland SJ, et al. Urology. 2003 Feb;61(2):365-9. doi: 10.1016/s0090-4295(02)02268-9. Urology. 2003. PMID: 12597949

9

Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy.

Freedland SJ, deGregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Dorey F, Reiter RE, Aronson WJ. Freedland SJ, et al. J Urol. 2003 Apr;169(4):1325-30. doi: 10.1097/01.ju.0000054004.08958.f3. J Urol. 2003. PMID: 12629353

10

Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database.

Freedland SJ, Aronson WJ, Csathy GS, Kane CJ, Amling CL, Presti JC Jr, Dorey F, Terris MK; SEARCH Database Study Group. Freedland SJ, et al. Urology. 2003 Apr;61(4):742-7. doi: 10.1016/s0090-4295(02)02525-6. Urology. 2003. PMID: 12670558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

780 results

Search Page

Filters